Anaplastic Large Cell Lymphoma Completed Phase 1 Trials for Capecitabine (DB01101)

Also known as: Lymphomas, Anaplastic Large-Cell / Anaplastic large-cell lymphoma / Large cell (Ki-1+) lymphoma / Lymphoma, Large-Cell, Anaplastic / Anaplastic large cell lymphoma, CD30-positive

IndicationStatusPhase
DBCOND0028602 (Anaplastic Large Cell Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01158274RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsTreatment